SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001103021-20-000073
Filing Date
2020-05-07
Accepted
2020-05-07 16:17:14
Documents
60
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bdsi-20200331.htm   iXBRL 10-Q 1129900
2 EX-31.1 bdsi-20200331x10qex3111.htm EX-31.1 9952
3 EX-31.2 bdsi-20200331x10qex3121.htm EX-31.2 9988
4 EX-32.1 bdsi-20200331x10qex3211.htm EX-32.1 6002
5 EX-32.2 bdsi-20200331x10qex3221.htm EX-32.2 6056
  Complete submission text file 0001103021-20-000073.txt   5015722

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bdsi-20200331.xsd EX-101.SCH 32038
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bdsi-20200331_cal.xml EX-101.CAL 58571
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bdsi-20200331_def.xml EX-101.DEF 182315
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bdsi-20200331_lab.xml EX-101.LAB 400214
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bdsi-20200331_pre.xml EX-101.PRE 280807
43 EXTRACTED XBRL INSTANCE DOCUMENT bdsi-20200331_htm.xml XML 871310
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31361 | Film No.: 20856663
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences